Twist Bioscience Settles With Agilent, Reports 49 Percent Rise in Fiscal Q1 Revenues

Feb 06, 2020

|

NEW YORK – Twist Bioscience reported after the close of the market on Thursday that its first quarter revenues in fiscal year 2020 increased 49 percent year over year.

Separately, the firm announced that it had reached a settlement agreement with Agilent Technologies over an intellectual property lawsuit Agilent had filed in 2016. Earlier in the day, speculation about an impending settlement had led to a sharp rise in Twist's share price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Boosting Viral Surveillance

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

California Strain

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

Nucleic Acids Research Studies on Pan-Cancer MiRNA Biogenesis Mutations, Skeletal Methylation, More

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

Lander Nominated for Science Advisor

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Featured White Papers

In-depth Quantification of Cell and Gene Therapy DNA Integrations Enabled with Single-cell Sequencing

Deep Understanding of Cell and Gene Therapy Genome Editing Protocols Enabled With Single-cell Sequencing

Illuminating the Role of the Adaptive Immune Response in Neurodegeneration

Transcriptional Profiling of 1.3 Million Brain Cells with the Chromium Single Cell Gene Expression Solution

Jan

26

Featured Webinar

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Reduced representation next-generation sequencing (NGS) methods are driving understanding of both physical and structural variation in all species.

Jan

28

Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources.

Feb

11

Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb

17

Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Menu

Twist Bioscience Settles With Agilent, Reports 49 Percent Rise in Fiscal Q1 Revenues

To read the full story....

Breaking News

Oncocyte to Raise $25M in Stock Sale to Institutional Investors

Invitae to Raise $400M in Proposed Public Offering

Natera Sues Inivata, Alleging Infringement of Cancer Testing Patents

Cellink to Distribute Phasefocus High-Content Cell Imaging Platform

Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines

Bionano Genomics to Raise $200M in Public Stock Offering

The Scan

Boosting Viral Surveillance

California Strain

Nucleic Acids Research Studies on Pan-Cancer MiRNA Biogenesis Mutations, Skeletal Methylation, More

Lander Nominated for Science Advisor

Featured White Papers

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

What's Popular?

Quest Diagnostics Wins CDC Contract to Sequence SARS-CoV-2 Samples

Ancestry to Discontinue NGS-Based AncestryHealth Service

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan

Devyser Receives €750K Grant to Build Sequencing Assay for Early Detection of Transplant Rejection

Sponsorships